Improving glaucoma treatment adherence in under-represented minorities
iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minorities
This study is working to help African Americans and Latinos with glaucoma stick to their treatment plans better by using smart technology to create personalized support that fits their unique needs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10755271 on NIH RePORTER |
What this research studies
This research focuses on enhancing adherence to glaucoma treatment among under-represented minorities, particularly African Americans and Latinos, who face higher rates of the disease and lower medication adherence. The project utilizes advanced health information technology, including electronic health records and mobile health technologies, to develop personalized interventions that address individual circumstances affecting medication management. By leveraging artificial intelligence, the study aims to create effective tools for monitoring and improving treatment adherence in real-world settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American and Latino individuals diagnosed with glaucoma who struggle with medication adherence.
Not a fit: Patients who are not from under-represented minority groups or those who do not have glaucoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve treatment adherence for glaucoma patients, potentially reducing the risk of blindness and lowering healthcare costs.
How similar studies have performed: Previous research has shown that technology-based interventions can improve medication adherence, but this approach specifically targeting under-represented minorities is novel.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Weinreb, Robert N — University of California, San Diego
- Study coordinator: Weinreb, Robert N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.